You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 021056


✉ Email this page to a colleague

« Back to Dashboard


NDA 021056 describes TARGRETIN, which is a drug marketed by Valeant Luxembourg and Bausch and is included in two NDAs. It is available from two suppliers. Additional details are available on the TARGRETIN profile page.

The generic ingredient in TARGRETIN is bexarotene. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bexarotene profile page.
Summary for 021056
Tradename:TARGRETIN
Applicant:Bausch
Ingredient:bexarotene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021056
Suppliers and Packaging for NDA: 021056
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TARGRETIN bexarotene GEL;TOPICAL 021056 NDA Bausch Health US, LLC 0187-5525 0187-5525-60 1 TUBE in 1 CARTON (0187-5525-60) / 60 g in 1 TUBE
TARGRETIN bexarotene GEL;TOPICAL 021056 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-002 68682-002-60 1 TUBE in 1 CARTON (68682-002-60) / 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength1%
Approval Date:Jun 28, 2000TE:ABRLD:Yes

Expired US Patents for NDA 021056

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bausch TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bausch TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.